AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 152 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $680,000 | +78.9% | 50,074 | -0.3% | 0.20% | -29.7% |
| Q1 2020 | $380,000 | +8.0% | 50,238 | -9.8% | 0.29% | +120.0% |
| Q4 2019 | $352,000 | -39.9% | 55,725 | -62.8% | 0.13% | -62.2% |
| Q3 2019 | $586,000 | -67.1% | 149,619 | -59.3% | 0.34% | -58.9% |
| Q2 2019 | $1,780,000 | -42.5% | 367,870 | -2.6% | 0.84% | -25.0% |
| Q1 2019 | $3,093,000 | +21.8% | 377,720 | -17.8% | 1.12% | +63.2% |
| Q4 2018 | $2,540,000 | – | 459,457 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
| Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
| Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
| Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
| Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
| Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
| PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
| Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |